Matt And Paul Blog Visual Edited 4

No one ever said commercializing a new product would be easy, but for healthcare companies, it seems to be especially tough - in large part due to the many players involved, their convoluted and misaligned incentives, and some truly byzantine power dynamics governing the system.

Keep me posted!
Paul Sequeira

Paul Sequeira came to Newry in 2015 from Thermalin Diabetes, a Cleveland biotech startup, where he was involved in new product development and supported efforts to secure venture capital funding. As a Newry consultant, Paul has led engagements in markets ranging from automotive to semiconductors, and many of his recent…

Full Bio
View All Posts